Finance

Lists
ELIC:STO
Elicera Therapeutics AB
2,76 SEK
-0,54%
(-0,015) 1D
9-окт., 17:29:31 GMT+2  ·   SEK
All symbols
SymbolPriceChange% Change
Generating top insights for ELIC...
Open
2,76 SEK
High
2,79 SEK
Low
2,68 SEK
Mkt. cap
183,86 млн
Avg. vol.
273,69 миң
Volume
155,48 миң
52-wk high
7,37 SEK
52-wk low
2,24 SEK
EPS
-0,35 SEK
Shares outstanding
66,74 млн
No. of employees
3
Open
2,76 SEK
High
2,79 SEK
Low
2,68 SEK
Mkt. cap
183,86 млн
Avg. vol.
273,69 миң
Volume
155,48 миң
52-wk high
7,37 SEK
52-wk low
2,24 SEK
EPS
-0,35 SEK
Shares outstanding
66,74 млн
No. of employees
3
News stories
From web sources and news partners
About Elicera Therapeutics AB
CEO-
Employees3
Founded2014
Headquarters-
Sector-
Previous reportsAll values in SEK
Loading Previous Earnings...
Revenue
Net income
All values in SEK
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
7,91 млн
30,00 миң
-
-147,66 миң
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
7,76 млн
7,16 млн
5,12 млн
6,16 млн
Operating expense
7,76 млн
7,16 млн
5,12 млн
6,16 млн
Total operating expenses
7,76 млн
7,16 млн
5,12 млн
6,16 млн
Operating income
146,69 миң
-7,13 млн
-5,12 млн
-6,31 млн
Other non operating income
1,32 миң
-
-
-4,00 миң
EBT including unusual items
304,15 миң
-6,97 млн
-5,06 млн
-6,26 млн
EBT excluding unusual items
304,15 миң
-6,97 млн
-5,06 млн
-6,26 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
304,15 миң
-6,97 млн
-5,06 млн
-6,26 млн
Net profit margin
3,85%
-23 219,94%
-
4 240,78%
Earnings per share
-
-
-
-
Interest and investment income
156,14 миң
169,41 миң
61,50 миң
47,75 миң
Interest expense
-
-5,07 миң
-4,78 миң
-45,00
Net interest expenses
156,14 миң
164,34 миң
56,72 миң
47,71 миң
Depreciation and amortization charges
-
-
-
-
EBITDA
149,63 миң
-7,13 млн
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google колдонмолору